These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 552856)

  • 1. Criteria for selection of physiologically active substances (pharmacometry under screening conditions).
    Dmitrieva NV; Kaplun AB; Lobanov VI; Nizhnii SV; Piruzyan LA
    Biol Bull Acad Sci USSR; 1979; 6(6):780-7. PubMed ID: 552856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modes and classes of modes of action of physiologically active substances of receptor type under conditions of screening.
    Dmitrieva NV; Kaplun AB; Kosolapov SS; Lobanov VI; Nizhnii SV; Piruzyan LA; Pronin VI
    Biol Bull Acad Sci USSR; 1980; 7(3):223-8. PubMed ID: 7317510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Method for the primary selection of active antitumor alkylating preparations in vitro and in vivo].
    Montsevichiute-Eringene EV
    Vopr Onkol; 1975; 21(10):73-7. PubMed ID: 1189354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modalities and classes of modalities of action of physiologically active substances of the receptor type during screening].
    Dmitrieva NV; Kaplun AB; Kosolapov SS; Lobanov VI; Nizhniĭ SV
    Izv Akad Nauk SSSR Biol; 1980; (3):408-14. PubMed ID: 7391338
    [No Abstract]   [Full Text] [Related]  

  • 5. [Sensitivity of the primordia of various organs to chemical substances].
    Puchkov VF; Peterka M; Elinek R; Chebotar' NA
    Arkh Anat Gistol Embriol; 1987 Jun; 92(6):13-6. PubMed ID: 3632358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of the cumulative properties of chemical substances according to an index and standardized coefficient of cumulation].
    Shtabskiĭ BM; Kagan IuS
    Gig Sanit; 1974 Mar; 39(3):65-7. PubMed ID: 4825189
    [No Abstract]   [Full Text] [Related]  

  • 7. Increasing throughput in lead optimization in vivo toxicity screens.
    Meador V; Jordan W; Zimmermann J
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):72-8. PubMed ID: 11865675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and evaluation of anticancer agents.
    Zee-Cheng RK; Cheng CC
    Methods Find Exp Clin Pharmacol; 1988 Feb; 10(2):67-101. PubMed ID: 3283480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Method for the quantitative evaluation of the combined effect on the body of 2 or more harmful chemical factors].
    Manenko AK
    Gig Sanit; 1982 Oct; (10):70-2. PubMed ID: 7173654
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug safety and therapeutic index / Principles of pharmacological screening and of the clinical transferability of animal experiments results (author's transl)].
    Schneider B
    Arzneimittelforschung; 1982; 32(5):471-4. PubMed ID: 7201820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of preclinical toxicology to findings in early clinical trials.
    Grieshaber CK; Marsoni S
    Cancer Treat Rep; 1986 Jan; 70(1):65-72. PubMed ID: 3943115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of different methods for studying the cumulative properties of hazardous substances].
    Novikov SM; Fursova TN; Kozeeva EE; Porokhova LA; Arkhangel'skiĭ VI
    Gig Sanit; 1987 Sep; (9):41-4. PubMed ID: 3678869
    [No Abstract]   [Full Text] [Related]  

  • 13. Probability screening model.
    Dmitrieva NV; Nizhnii SV; Piruzyan LA; Polishchuk ES
    Biol Bull Acad Sci USSR; 1979; 6(4):423-31. PubMed ID: 549679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Principles, methods and criteria for assessing the effectiveness of potentially cardiotonic compounds at the preclinical research stage].
    Chekman IS; Tkachuk VV
    Farmakol Toksikol; 1984; 47(6):5-15. PubMed ID: 6394358
    [No Abstract]   [Full Text] [Related]  

  • 15. [The application of modern pharmacology to medical practice].
    Scholtholt J
    Fortschr Med; 1980 Aug; 98(30-31):1139-43. PubMed ID: 7419157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chick embryotoxicity screening test--130 substances tested.
    Jelinek R; Peterka M; Rychter Z
    Indian J Exp Biol; 1985 Oct; 23(10):588-95. PubMed ID: 3833676
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug discrimination in behavioral toxicology.
    Colpaert FC
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1987 Oct; 185(1-2):48-51. PubMed ID: 3124387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of structure generators in predictive pharmacology and toxicology.
    Wieland T
    Arzneimittelforschung; 1996 Feb; 46(2):223-7. PubMed ID: 8720320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substance identification by quantitative characterization of oscillatory activity in murine spinal cord networks on microelectrode arrays.
    Gramowski A; Jügelt K; Weiss DG; Gross GW
    Eur J Neurosci; 2004 May; 19(10):2815-25. PubMed ID: 15147315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical formulations for discovery and toxicology: physicochemical challenges.
    Neervannan S
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):715-31. PubMed ID: 17014391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.